Multispectroscopic insight,morphological analysis and molecular docking studies of CuII-based chemotherapeutic drug entity with human serum albumin (HSA) and bovine serum albumin (BSA)

The interaction studies of Cu^II nalidixic acid–DACH chemotherapeutic drug entity, [C₃₆H₅₀N₈O₆Cu] with serum albumin proteins, viz., human serum albumin (HSA) and bovine serum albumin (BSA) employing UV–vis, fluorescence, CD, FTIR and molecular docking techniques have been carried out. Complex [C₃₆H₅₀N₈O₆Cu] demonstrated strong binding affinity towards serum albumin proteins via hydrophobic contacts with binding constants, K?=?3.18?×?10⁵ and 7.44?×?10⁴ M^–1 for HSA and BSA, respectively implicating a higher binding affinity for HSA. The thermodynamic parameters ΔG, ΔH and ΔS at different temperatures were also calculated and the interaction of complex [C₃₆H₅₀N₈O₆Cu] with HSA and BSA was found to be enthalpy and entropy favoured, nevertheless, complex [C₃₆H₅₀N₈O₆Cu] demonstrated higher binding affinity towards HSA than BSA evidenced from its higher binding constant values. Time resolved fluorescence spectroscopy (TRFS) was carried out to validate the static quenching mechanism of HSA/BSA fluorescence. The collaborative results of spectroscopic studies indicated that the microenvironment and the conformation of HSA and BSA (α–helix) were significantly perturbed upon interaction with complex [C₃₆H₅₀N₈O₆Cu]. Hirshfeld surfaces analysis and fingerprint plots revealed various intermolecular interactions viz., N–H····O, O–H····O and C–H····O linkages in a 2–dimensional framework that provide crucial information about the supramolecular architectures in the complex. Molecular docking studies were carried out to ascertain the preferential binding mode and affinity of complex [C₃₆H₅₀N₈O₆Cu] at the target site of HSA and BSA. Furthermore, only for Transmission electroscopy microscopy micrographs of HSA and BSA in presence of complex [C₃₆H₅₀N₈O₆Cu] revealed major protein morphological transitions and aggregation which validates efficient delivery of complex by serum proteins to the target site.

Communicated by Ramaswamy H. Sarma     

Synthesis,Characterization, Molecular Modeling,and DNA Interaction Studies of Copper Complex Containing Food Additive Carmoisine Dye

A copper complex of carmoisine dye; [Cu(carmoisine)₂(H₂O)₂]; was synthesized and characterized by using physico-chemical and spectroscopic methods. The binding of this complex with calf thymus (ct) DNA was investigated by circular dichroism, absorption studies, emission spectroscopy, and viscosity measurements. UV-vis results confirmed that the Cu complex interacted with DNA to form a ground-state complex and the observed binding constant (2× 10⁴ M^?1) is more in keeping with the groove bindings with DNA. Furthermore, the viscosity measurement result showed that the addition of complex causes no significant change on DNA viscosity and it indicated that the intercalation mode is ruled out. The thermodynamic parameters are calculated by van't Hoff equation, which demonstrated that hydrogen bonds and van der Waals interactions played major roles in the reaction. The results of circular dichroism (CD) suggested that the complex can change the conformation of DNA from B-like form toward A-like conformation. The cytotoxicity studies of the carmoisine dye and its copper complex indicated that both of them had anticancer effects on HT-29 (colon cancer) cell line and they may be new candidates for treatment of the colon cancer.     

Study on the interaction of a copper(II) complex containing the artificial sweetener aspartame with human serum albumin

A copper(II) complex containing aspartame (APM) as ligand, Cu(APM)₂Cl₂·2H₂O, was synthesized and characterized. In vitro binding interaction of this complex with human serum albumin (HSA) was studied at physiological pH. Binding studies of this complex with HSA are useful for understanding the Cu(APM)₂Cl₂·2H₂O–HSA interaction mechanism and providing guidance for the application and design of new and more efficient artificial sweeteners drive. The interaction was investigated by spectrophotometric, spectrofluorometric, competition experiment and circular dichroism. Hyperchromicity observed in UV absorption band of Cu(APM)₂Cl₂·2H₂O. A strong fluorescence quenching reaction of HSA to Cu(APM)₂Cl₂·2H₂O was observed and the binding constant (K_f) and corresponding numbers of binding sites (n) were calculated at different temperatures. Thermodynamic parameters, enthalpy change (?H) and entropy change (?S) were calculated to be ?458.67 kJ mol^?1 and ?1,339 J mol^?1 K^?1 respectively. According to the van’t Hoff equation, the reaction is predominantly enthalpically driven. In conformity with experimental results, we suggest that Cu(APM)₂Cl₂·2H₂O interacts with HSA. In comparison with previous study, it is found that the Cu(II) complex binds stronger than aspartame.     

Interaction of copper (II) complexes by bovine serum albumin: spectroscopic and calorimetric insights

Serum albumins being the most abundant proteins in the blood and cerebrospinal fluid are significant carriers of essential transition metal ions in the human body. Studies of copper (II) complexes have gained attention because of their potential applications in synthetic, biological, and industrial processes. Study of binding interactions of such bioinorganic complexes with serum albumins improves our understanding of biomolecular recognition process essential for rational drug design. In the present investigation, we have applied quantitative approach to explore interactions of novel synthesized copper (II) complexes viz. [Cu(L¹)(L²)ClO₄] (complex I), [Cu(L²)(L³)]ClO₄] (complex II) and [Cu(L⁴)₂(H₂O)₂] (complex III) with bovine serum albumin (BSA) to evaluate their binding characteristics, site and mode of interaction. The fluorescence quenching of BSA initiated by complexation has been observed to be static in nature. The binding interactions are endothermic driven by entropic factors as confirmed by high sensitivity isothermal titration calorimetry. Changes in secondary and tertiary structure of protein have been studied by circular dichroism and significant reduction in α-helical content of BSA was observed upon binding. Site marking experiments with warfarin and ibuprofen indicated that copper complexes bind at site II of the protein.     

Synthesis,Characterization, and Biological Evaluation of Cu(II) Complexes Containing Triflupromazine with Glycine and Histidine

Two novel copper (II) complexes [Cu(TFP)(Gly)Cl] ⋅ 2H₂O complex ( 1 ) and [Cu(TFP)(His)Cl] ⋅ 2H₂O complex ( 2 ) are synthesized, where TFP stands for trifluropromazine, Gly. represents glycine, and His. is histidine. Chemical composition, IR, mass spectra, and magnetic susceptibility tests are performed. Complex binding with macromolecules was investigated using UV-vis, viscosity, gel electrophoresis, and fluorescence quenching. Fluorescence spectroscopy revealed that each complex could replace ethidium bromide (EB). These complexes exhibit grooved, non-covalent, and electrostatic interactions with CT-DNA. Spectroscopy analysis of the BSA interaction showed that complexes bind to protein (K_b values for ( 1 ) is 5.89×10³ M⁻¹ and for ( 2 ) is 9.08×10³ M⁻¹) more strongly than CT-DNA (K_b values for ( 1 ) is 5.43×10³ M⁻¹ and for ( 2 ) is 7.17×10³ M⁻¹). Molecular docking analysis and spectral absorption measurements showed high agreement. Antimicrobial, antioxidant, and anti-inflammatory properties were tested in vitro. The druggability of complex ( 2 ) should be tested in vivo as it is more biologically active.     

Synthesis and characterization of new oligomeric and polymeric complexes based on the [Cu(bpca)] unit [Hbpca = bis(2-pyridylcarbonyl)amine]

Five novel bpca-based Cu(II) polynuclear coordination compounds [Hbpca = bis(2-pyridylcarbonyl)amine] were prepared using the [Cu(bpca)(H₂O)₂](NO₃)·2H₂O (1) building block and characterized by single crystal X-ray diffraction. We have also isolated and characterized two new crystal forms of the starting species, with lower water contents. Three of the new products are dinuclear complexes obtained by reacting 1 with different rigid or flexible spacer ligands: [Cu₂(bpca)₂(H₂O)₂(bipy)](NO₃)₂·6H₂O (2) (bipy = 4,4′-bipyridine) and [Cu₂(bpca)₂(H₂O)₂(bpete)](NO₃)₂·xH₂O (3) [bpete = (E)-1,2-di(pyridin-4-yl)ethane] are linear dumbbell-like species with Cu?Cu separations of 11.075 and 13.275 Å, respectively. The third dinuclear compound, [Cu₂(bpca)₂(H₂O)₂(bpx)](NO₃)₂·8H₂O (4) [bpx = 1,4-bis((1H-pyrazol-1-yl)methyl)benzene], with the flexible bpx ligand, assumes an unusual S-shaped conformation and shows a quite shorter Cu?Cu contact of 6.869 Å only. We have also obtained a chiral 1D neutral polymeric complex, [Cu₃(bpca)₂(bipy)₃(NO₃)₄]·6H₂O (5), that shows a central linear -Cu-bipy-Cu- chain, with all these Cu atoms connected to two lateral [Cu(bpca)(NO₃)₂]⁻ groups on two opposite sides by means of bipy spacers. An unprecedented type of Cu(II) neutral trinuclear complex, [Cu₃(bpca)₂(H₂O)₂(NO₃)₂] (6), was obtained which has a centrosymmetric structure with two external [Cu(bpca)(NO₃)₂]⁻ units chelating on a central copper atom via the two pairs of carbonyl groups of the bpca ligands. The central metal is octahedral with two axial water molecules, while the two lateral Cu atoms are in square pyramidal geometry; the Cu?Cu separation is 5.205 Å. The magnetic properties of 6 have been rationalized through a ferromagnetic coupling between the central metal ion and the peripheral ones which are coupled by a smaller antiferromagnetic interaction. DFT calculations have been also performed in order to give a better insight into magnetic interactions.     

Binding analysis of ytterbium(III) complex containing 1,10-phenanthroline with DNA and its antimicrobial activity

To evaluate the biological preference of [Yb(phen)₂(OH₂)Cl₃](H₂O)₂ (phen is 1,10-phenanthroline) for DNA, interaction of Yb(III) complex with DNA in Tris–HCl buffer is studied by various biophysical and spectroscopic techniques which reveal that the complex binds to DNA. The results of fluorescence titration reveal that [Yb(phen)₂(OH₂)Cl₃](H₂O)₂ has strongly quenched in the presence of DNA. The binding site number n, apparent binding constant K _b, and the Stern–Volmer quenching constant K _SV are determined. ΔH ⁰, ΔS ⁰, and ΔG ⁰ are obtained based on the quenching constants and thermodynamic theory (ΔH ⁰?>?0, ΔS ⁰?>?0, and ΔG ⁰?<?0). The experimental results show that the Yb(III) complex binds to DNA by non-intercalative mode. Groove binding is the preferred mode of interaction for [Yb(phen)₂(OH₂)Cl₃](H₂O)₂ to DNA. The DNA cleavage results show that in the absence of any reducing agent, Yb(III) complex can cleave DNA. The antimicrobial screening tests are also recorded and give good results in the presence of Yb(III) complex.     

Synthesis,characterization, DNA interaction,and cytotoxicity of novel Pd(II) and Pt(II) complexes

Four complexes [Pd(L)(bipy)Cl]·4H₂O (1), [Pd(L)(phen)Cl]·4H₂O (2), [Pt(L)(bipy)Cl]·4H₂O (3), and [Pt(L)(phen)Cl]·4H₂O (4), where L = quinolinic acid, bipy = 2,2’-bipyridyl, and phen = 1,10-phenanthroline, have been synthesized and characterized using IR, ¹H NMR, elemental analysis, and single-crystal X-ray diffractometry. The binding of the complexes to FS-DNA was investigated by electronic absorption titration and fluorescence spectroscopy. The results indicate that the complexes bind to FS-DNA in an intercalative mode and the intrinsic binding constants K of the title complexes with FS-DNA are about 3.5?×?10⁴ M^?1, 3.9?×?10⁴ M^?1, 6.1?×?10⁴ M^?1, and 1.4?×?10⁵ M^?1, respectively. Also, the four complexes bind to DNA with different binding affinities, in descending order: complex 4, complex 3, complex 2, complex 1. Gel electrophoresis assay demonstrated the ability of the Pt(II) complexes to cleave pBR322 plasmid DNA.     

Synthesis and characterization of new unsaturated macrobicyclic and bis(macrocyclic) copper(II) complexes containing N-CH2-N linkages

New copper(II) complexes [CuL²]²⁺ (L²=7,7,9-trimethyl-1,3,6,10,13-pentaazabicyclo[11,2,1^1.13]hexadec-9-ene) and [Cu₂(L³)(H₂O)₂]⁴⁺ have been prepared by the reaction of [CuL¹]²⁺ (L¹=5,5,7-trimethyl-1,4,8,11,14-pentaazatetradce-7-ene) and formaldehyde. The mononuclear complex [CuL²]²⁺ has a square-planar coordination geometry with a 5-6-5-6 chelate ring sequence and is relatively stable even in low pH at room temperature. The dinuclear complex [Cu₂(L³)(H₂O)₂]⁴⁺ consists of two unsaturated 15-membered pentaaza macrocyclic units (7,7,9-trimethyl-1,3,6,10,13-pentaazacyclopentadec-9-ene) that are linked together by a methylene group in a tilted face-to-face arrangement [Cu?Cu distance: 7.413(2) Å ]. Each macrocyclic unit of [Cu₂(L³)(H₂O)₂]⁴⁺ contains one four-membered chelate ring and has a severely distorted octahedral coordination polyhedron. The dinuclear complex is quite stable in aqueous solutions containing an excess of formaldehyde or in dry acetonitrile but is decomposed to [CuL¹]²⁺ and [CuL²]²⁺ in pure water.     

Antibacterial,antifungal and in vitro antileukaemia activity of metal complexes with thiosemicarbazones

1‐phenyl‐3‐methyl‐4‐benzoyl‐5‐pyrazolone 4‐ethyl‐thiosemicarbazone (HL) and its copper(II), vanadium(V) and nickel(II) complexes: [Cu(L)(Cl)]·C₂H₅OH·( 1 ), [Cu(L)₂]·H₂O ( 2 ), [Cu(L)(Br)]·H₂O·CH₃OH ( 3 ), [Cu(L)(NO₃)]·2C₂H₅OH ( 4 ), [VO₂(L)]·2H₂O ( 5 ), [Ni(L)₂]·H₂O ( 6 ), were synthesized and characterized. The ligand has been characterized by elemental analyses, IR, ¹H NMR and ¹³C NMR spectroscopy. The tridentate nature of the ligand is evident from the IR spectra. The copper(II), vanadium(V) and nickel(II) complexes have been characterized by different physico‐chemical techniques such as molar conductivity, magnetic susceptibility measurements and electronic, infrared and electron paramagnetic resonance spectral studies. The structures of the ligand and its copper(II) ( 2 , 4 ), and vanadium(V) ( 5 ) complexes have been determined by single‐crystal X‐ray diffraction. The composition of the coordination polyhedron of the central atom in 2 , 4 and 5 is different. The tetrahedral coordination geometry of Cu was found in complex 2 while in complex 4 , it is square planar, in complex 5 the coordination polyhedron of the central ion is distorted square pyramid. The in vitro antibacterial activity of the complexes against Escherichia coli, Salmonella abony, Staphylococcus aureus, Bacillus cereus and the antifungal activity against Candida albicans strains was higher for the metal complexes than for free ligand. The effect of the free ligand and its metal complexes on the proliferation of HL‐60 cells was tested.     

New binary copper(II) complexes containing intercalating ligands: DNA interactions,an unusual static quenching mechanism of BSA and cytotoxic activities

New binary copper(II) complexes – [Cu(4-mphen)₂(NO₃)]NO₃·H₂O (1), [Cu(5-mphen)₂ (NO₃)]NO₃·H₂O (2), the known complex [Cu(dmphen)₂(NO₃)]NO₃ (3) and [Cu(tmphen)₂ (NO₃)]NO₃·H₂O (4) - (4-mphen: 4-methyl-1,10-phenanthroline, 5-mphen: 5-methyl-1,10-phenanthroline, dmphen: 4,7-dimethyl-1,10-phenanthroline, tmphen: 3,4,7,8-tetramethyl-1,10-phenanthroline), have been synthesized and characterized by CHN analysis, ESI-MS, FTIR and single-crystal X-ray diffraction techniques. Interaction of these complexes with calf thymus DNA (CT-DNA) has been investigated by absorption spectral titration, ethidium bromide (EB) and Hoechst 33,258 displacement assay and thermal denaturation measurement. These complexes cleaved pUC19 plasmid DNA in the absence and presence of an external agent. Notably, in the presence of H₂O₂ as an activator, the cleavage abilities of these complexes are obviously enhanced at low concentration. Addition of hydroxyl radical scavengers like DMSO shows significant inhibition of the DNA cleavage activity of these complexes. BSA quenching mechanism was investigated with regard to the type of quenching, binding constant, number of binding locations and the thermodynamic parameters. The experimental results suggested that the probable quenching mechanism was an unusual static process and hydrophobic forces play a dominant role. The CT-DNA and BSA binding efficiencies of these complexes follow the order: 4 > 3 > 1 > 2. Furthermore, in vitro cytotoxicities of these complexes on tumor cells lines (Caco-2, MCF-7 and A549) and healthy cell line (BEAS-2B) showed that these complexes exhibited anticancer activity with low IC₅₀ values. The effect of hydrophobicity of the methyl-substituted phenanthrolines on DNA and protein binding activities of these complexes is discussed.     

Oligomerization of the Cu(II) and Ni(II) tetraazaannulene complexes: A pulse radiolysis study of the associated reaction mechanism

The oligomerization of [Cu^II(H_x(tmdnTAA))]^x+ (x = 0, 1, 2 and (tmdnTAA))²⁻ is 2,4,9,11-tetramethyl-dinaphto[14]-2,4,6,9,11,13-hexaeneN₄) was initiated in homogeneous solution via the reaction of this Cu(II) complex with pulse radiolytically generated radicals. The reaction produces Cu(III) intermediates which are rapidly converted to Cu(II) ligand-radical species. In contrast to the mechanism proposed for the electrochemical oligomerization, where the local concentration of radicals is probably high, the reaction kinetics in homogeneous solution is propagated by a process where the Cu(II) ligand-radical precursors react with [Cu^II(H_x(tmdnTAA))]^x+.     

Determination of superoxide dismutase-like activity in some divalent metal saccharinates

The superoxide-dismutase-like activity of a series of divalent metal saccharinates of general stoichiometry [M^II(Sac)₂(H₂O)₄]·2H₂O (with M^II=Mn,Fe,Co,Ni,Cu,Zn) has been investigated using the nitroblue tetrazolium O ₂ ⁻ reduction assay. The results show that all these complexes possess the capability to dismutate the superoxide anion generated in the xanthine/xanthine oxidase system. Interestingly, the greatest activity is shown by the corresponding copper complex. The results are discussed and compared with those obtained for native superoxide dismutase, which was tested under the same experimental conditions. Dedicated to Prof. Pedro J. Aymonino on the occasion of his 65^th birthday.     

Copper(II) pyridinecarboxylate adducts with chelating ligands as potential antimicrobial agents

The synthesis and characterization of seven new solid complexes, [Cu(2-MeSnic)₂ (phen)] (2-MeSnic = 2-methylthionicotinate, phen = 1,10-phenanthroline), [CuX₂(bipy)(H₂O)] (X = 2-MeSnic or nic (nicotinate), bipy = 2,2′-bipyridine), [Cu(isonic)₂(bipy)(H₂O)] · H₂O (isonic = isonicotinate), [Cu(bipy)₂(H₂O)](2-MeSnic)₂ · 3H₂O, [Cu(phen)₂(H₂O)](isonic) ₂ · 2H₂O and [Cu(phen)₂(H₂O)](nic)₂ · 3H₂O, are reported. The composition and stereochemistry as well as the mode of ligand coordination have been determined by elemental analysis, IR, electronic and EPR spectra. The carboxyl group of the pyridinecarboxylate anions coordinates to the Cu(II) atom as an unidentate or as a chelating ligand. The EPR spectra of studied complexes are monomeric except for the spectrum of [Cu(2-MeSnic)₂(bipy)(H₂O)], which shows triplet state feature. Half-field transition, observed for [Cu(2-MeSnic)₂(bipy)(H₂O)], [Cu(bipy)₂(H₂O)](2-MeSnic)₂ · 3H₂O and [Cu(phen)₂(H₂O)](nic)₂ · 3H₂O, was used to estimate the interspin copper-copper distances. In all cases, the available evidence supports square-pyramidal environment about the copper(II) atom, which is confirmed by crystal and molecular structure of one of the products, namely [Cu(2-MeSnic)₂(bipy)(H₂O)]. The antimicrobial effects have been tested on various strains of bacteria, yeasts and filamentous fungi.     

Biological and protein‐binding studies of newly synthesized polymer–cobalt(III) complexes

The polymer–cobalt(III) complexes, [Co(bpy)(dien)BPEI]Cl₃ · 4H₂O (bpy = 2,2′‐bipyridine, dien = diethylentriamine, BPEI = branched polyethyleneimine) were synthesized and characterized. The interaction of these complexes with human serum albumin (HSA) and bovine serum albumin (BSA) was investigated under physiological conditions using various physico‐chemical techniques. The results reveal that the fluorescence quenching of serum albumins by polymer–cobalt(III) complexes took place through static quenching. The binding of these complexes changed the molecular conformation of the protein considerably. The polymer–cobalt(III) complex with x = 0.365 shows antimicrobial activity against several human pathogens. This complex also induces cytotoxicity against MCF‐7 through apoptotic induction. However, further studies are needed to decipher the molecular mode of action of polymer–cobalt(III) complex and for its possible utilization in anticancer therapy. Copyright © 2015 John Wiley & Sons, Ltd.     

Spectroscopic differences between heterocyclic benzothiazoline, -thiazole and imine containing ligands and comparison of the Co and Cu pyridine benzothiazole and imine complexes

Five heterocyclic benzothiazoline and -thiazole analogs have been synthesized and characterized by ¹H NMR and IR spectroscopy. The analogs fall into two different classes, (a) those which contain one benzothiazoline group adjacent to the heterocyclic ring system (starting with 2-pyridinecarboxaldehyde, 2-thiophenecarboxaldehyde or 2-furaldehyde), and (b) those which have two benzothiazoline substituents (starting with 2,6-pyridinecarboxaldehyde and 2,5-thiohenecarboxaldehyde). In addition, the imine containing ligands, bis-2-[(pyridin-2-ylmethylene)-imino]-benzenethiol disulfide (PyIS)₂ and bis-2-[(thiophen-2-ylmethylene)-imino]-benzenethiol disulfide(ThIS)₂, were prepared starting with the disulfide of 2-aminothiophenol. Each species has been characterized by ¹H NMR and IR spectroscopies. Ligation reactions with 2-(2-pyridyl)benzothiazoline (Py(Bt)) and Cu(OAc)₂·1H₂O resulted in the formation of a dinuclear species containing two copper ions, two ligand frames and two acetate groups, [Cu(PyAS)(OAc)]₂ (1). Both copper ions are five-coordinate and bonded to one monodentate acetate, one ligand frame (NNS) and one bridging thiolate. Ligation reaction with 2-(2-pyridyl)benzothiazole (Py(oBt)) and CoCl₂·xH₂O or Cu(BF₄)₂·xH₂O resulted in the formation of a six-coordinate, octahedral Co(II) complex, cis-[Co(Py(oBt)₂Cl₂] (2) and a five coordinate Cu(II) complex, [Cu(Py(oBt))₂(OH₂)](BF₄) (3), respectively. All complexes have been characterized by X-ray crystallography as well as UV-Vis and IR spectroscopy.     

Binuclear copper and zinc complexes based on polypyridyl ligand 2,3,5,6-tetra(2-pyridyl)pyrazine (tppz): Synthesis, spectral and structural characterization

The reaction of MCl₂ · 2H₂O (M = Cu, Zn) with 2,3,5,6-tetra(2-pyridyl)pyrazine (tppz) (referred hereafter as L) in 2:1 molar ratio in acetonitrile at room temperature afforded binuclear complexes [M₂(κ³-L)Cl₄] [Cu (1), Zn (2)] where the ligand is bis-tridentate manner. The complexes have been characterized by elemental analyses, FAB-MS, IR, EPR, NMR and electronic spectral studies. Solid state structures of both the [Cu₂(κ³-L)Cl₄] · 5H₂O (1), [Zn₂(κ³-L)Cl₄] · H₂O (2) have been determined by single crystal X-ray analyses. A well-resolved uudd cyclic water tetramer and water monomer were reported in the crystal host of [Cu₂(κ³-L)Cl₄] · 5H₂O (1) and [Zn₂(κ³-L)Cl₄] · H₂O (2) showing the contribution of the water cluster to the stability of the crystal host 1 and 2.     

2-Benzoylpyridine and copper(II) ion in basic medium: Hydroxide nucleophilic addition stabilized by metal complexation, reactivity, crystal structure, DNA binding study and magnetic behavior

On reaction of 2-benzoylpyridine (Bzpy) with copper(II) ion, different types of copper(II) complexes have been isolated in pure form depending upon the counter anion of the copper(II) salts used as reactant and the pH of the medium. Mono-nuclear copper(II) complexes of formula [Cu(Bzpy)₂(ClO₄)₂] (1) and [Cu(Bzpy)₂(H₂O)₂](NO₃)₂ (2) were formed with copper(II) perchlorate and nitrate, respectively. On the other hand, following a similar reaction type in presence of alkali, we obtained the dinuclear copper(II) complex [Cu₂(Bzpy)₂{BzOpy}₂(H₂O)](ClO₄)₂ (3) containing the hydroxy-2-pyridylphenylmethanolato (BzOpy)⁻ anion, achieved through the nucleophilic addition of the hydroxide to the carbonyl group of Bzpy, which is stabilized by metal complexation. However, this behavior was not recorded with copper(II) nitrate. The complexes were characterized by physicochemical and spectroscopic tools along with structural characterization by single crystal X-ray diffraction analysis. The interaction of dinuclear copper(II) complex 3 with calf thymus DNA (CT-DNA) has been investigated by using absorption and emission spectral studies and the binding constant (K_b) and the linear Stern-Volmer quenching constant (K_sv) have been determined. Complex 3 was active to oxidize the catechol to the corresponding quinone in MeCN medium via complex-catechol intermediate. Magnetic behavior for 3 is typical for uncorrelated spins down even up to 2 K.     

Heterometallic coordination compounds of dipicolinic acid with Ce(III, IV) and Cu(II): Synthesis, crystal structure and spectral studies

Reaction of pyridine-2,6-dicarboxylic acid (dipicH₂) with ammonium ceric nitrate and Cu(II) salts yielded three heterometallic compounds all of which contain [Ce(dipic)₃]²⁻ linked to aquo-Cu(II) complex units. Part of the Ce(IV) gets reduced by solvent during the reaction leading to [(Ce(dipic)₃Ce(H₂O)₈)₂Cu(H₂O)₄][Ce(dipic)₃]₂·12H₂O (1). Other lanthanide(III) ions could take the place of Ce(III) as demonstrated by the preparation of [(Ce(dipic)₃La(H₂O)₈)₂Cu(H₂O)₄][Ce(dipic)₃]₂·12H₂O (4), which is isomorphous with compound 1. [Ce(dipic)₃Cu(H₂O)₄]·8H₂O (2) is a one-dimensional coordination polymer in which two types of aquo-Cu(II) complex units which differ in the orientation of the tetragonal axis alternate along the chain. The central Cu(H₂O)₂²⁺ unit in the trinuclear anion of [Cu(H₂O)₆][Ce(dipic)₃Cu(H₂O)₂Ce(dipic)₃]·8H₂O (3) is chelated by two carboxylate groups in trans positions in off-axis mode. In all the four complexes, the Cu(II) centres are magnetically isolated leading well-resolved EPR spectra in polycrystalline samples.     

A Novel Cytotoxic Cerium Complex: Aquatrichloridobis(1,10‐phenanthroline)cerium(III) (KP776). Synthesis,Characterization, Behavior in H2O,Binding towards Biomolecules,and Antiproliferative Activity

The lanthanide complex aquatrichloridobis(1,10‐phenanthroline)cerium(III) [Ce(phen)₂(H₂O)Cl₃] (KP776) was fully characterized by elemental analysis, IR‐, and ¹H‐ and ¹³C‐NMR spectroscopy, as well as TG/DTA measurements, and its behavior in H₂O, important for the application as a chemotherapeutic, was studied. In addition, the binding of KP776 to nucleotides and single serum proteins was investigated by capillary electrophoresis, whereas binding to proteins in human plasma was observed by ICP‐MS. The compound shows promising anticancer properties in vitro: proliferation of human cancer cell lines is strongly inhibited with IC₅₀ values in the very low micromolar range.